Patent classifications
C07C45/71
NICOTINYL ALCOHOL ETHER DERIVATIVE, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION AND USES THEREOF
The present invention discloses a nicotinyl alcohol ether derivative, a preparation method therefor, and a pharmaceutical composition and uses thereof. Specifically, the invention relates to nicotinyl alcohol ether derivatives represented by formula (I), a pharmaceutically-acceptable salt thereof, a stereoisomer thereof, a preparation method therefor, a pharmaceutical composition containing the one or more compounds, and uses of the compounds in treating diseases related to PD-1/PD-L1 signal channels, such as cancers, infectious diseases and autoimmune diseases.
##STR00001##
Benzyl phenyl ether derivative, preparation method therefor, and pharmaceutical composition and uses thereof
The present invention discloses a benzyl phenyl ether derivative, a preparation method therefor, and a pharmaceutical composition and uses thereof. Specifically, the invention relates to benzyl phenyl ether derivatives represented by formula (I), a pharmaceutically-acceptable salt thereof, a stereoisomer thereof, a preparation method therefor, a pharmaceutical composition containing the one or more compounds, and uses of the compounds in treating diseases related to PD-1/PD-L1 signal channels, such as cancers, infectious diseases and autoimmune diseases. ##STR00001##
Benzyl phenyl ether derivative, preparation method therefor, and pharmaceutical composition and uses thereof
The present invention discloses a benzyl phenyl ether derivative, a preparation method therefor, and a pharmaceutical composition and uses thereof. Specifically, the invention relates to benzyl phenyl ether derivatives represented by formula (I), a pharmaceutically-acceptable salt thereof, a stereoisomer thereof, a preparation method therefor, a pharmaceutical composition containing the one or more compounds, and uses of the compounds in treating diseases related to PD-1/PD-L1 signal channels, such as cancers, infectious diseases and autoimmune diseases. ##STR00001##
METHOD FOR CONVERTING HYDROXYL GROUP OF ALCOHOL
The present invention relates to: a method for converting a hydroxyl group of an alcohol; and a catalyst which makes the method possible. A method for converting a hydroxyl group of an alcohol according to the present invention is characterized by producing a compound represented by CH(R.sup.1)(R.sup.2)Nu (wherein R.sup.1, R.sup.2 and Nu are as defined below) by reacting an alcohol represented by CH(R.sup.1)(R.sup.2)OH (wherein each of R.sup.1 and R.sup.2 represents a hydrogen atom, an optionally substituted alkyl group, or the like) and a compound having an active proton, which is represented by H-Nu (wherein Nu represents a group represented by CHX.sup.1-EWG.sup.1 or NR.sup.3R.sup.4; X.sup.1 represents a hydrogen atom or the like; EWG.sup.1 represents an electron-withdrawing group; and each of R.sup.3 and R.sup.4 represents a hydrogen atom, an optionally substituted alkyl group, or the like), with each other in the presence of a complex of a group 7-11 metal of the periodic table and at least one solid base that is selected from the group consisting of layered double hydroxides, composite oxides and calcium hydroxide.
METHOD FOR CONVERTING HYDROXYL GROUP OF ALCOHOL
The present invention relates to: a method for converting a hydroxyl group of an alcohol; and a catalyst which makes the method possible. A method for converting a hydroxyl group of an alcohol according to the present invention is characterized by producing a compound represented by CH(R.sup.1)(R.sup.2)Nu (wherein R.sup.1, R.sup.2 and Nu are as defined below) by reacting an alcohol represented by CH(R.sup.1)(R.sup.2)OH (wherein each of R.sup.1 and R.sup.2 represents a hydrogen atom, an optionally substituted alkyl group, or the like) and a compound having an active proton, which is represented by H-Nu (wherein Nu represents a group represented by CHX.sup.1-EWG.sup.1 or NR.sup.3R.sup.4; X.sup.1 represents a hydrogen atom or the like; EWG.sup.1 represents an electron-withdrawing group; and each of R.sup.3 and R.sup.4 represents a hydrogen atom, an optionally substituted alkyl group, or the like), with each other in the presence of a complex of a group 7-11 metal of the periodic table and at least one solid base that is selected from the group consisting of layered double hydroxides, composite oxides and calcium hydroxide.
METHOD FOR CONVERTING HYDROXYL GROUP OF ALCOHOL
The present invention relates to: a method for converting a hydroxyl group of an alcohol; and a catalyst which makes the method possible. A method for converting a hydroxyl group of an alcohol according to the present invention is characterized by producing a compound represented by CH(R.sup.1)(R.sup.2)Nu (wherein R.sup.1, R.sup.2 and Nu are as defined below) by reacting an alcohol represented by CH(R.sup.1)(R.sup.2)OH (wherein each of R.sup.1 and R.sup.2 represents a hydrogen atom, an optionally substituted alkyl group, or the like) and a compound having an active proton, which is represented by H-Nu (wherein Nu represents a group represented by CHX.sup.1-EWG.sup.1 or NR.sup.3R.sup.4; X.sup.1 represents a hydrogen atom or the like; EWG.sup.1 represents an electron-withdrawing group; and each of R.sup.3 and R.sup.4 represents a hydrogen atom, an optionally substituted alkyl group, or the like), with each other in the presence of a complex of a group 7-11 metal of the periodic table and at least one solid base that is selected from the group consisting of layered double hydroxides, composite oxides and calcium hydroxide.
Process for the preparation of Safinamide Mesylate intermediate
The present application provides methods for the synthesis of intermediates in the synthesis of Safinamide or a pharmaceutically acceptable salt thereof herein Safinamide Mesylate, that is substantially free of impurities.
Process for the preparation of Safinamide Mesylate intermediate
The present application provides methods for the synthesis of intermediates in the synthesis of Safinamide or a pharmaceutically acceptable salt thereof herein Safinamide Mesylate, that is substantially free of impurities.
AMINATED LIGNIN-DERIVED COMPOUNDS AND USES THEREOF
The present invention relates to novel lignin-derived compounds and compositions comprising the same and their use as redox flow battery electrolytes. The invention further provides a method for preparing said compounds and compositions as well as a redox flow battery comprising said compounds and compositions. Additionally, an assembly for carrying out the inventive method is provided.
AMINATED LIGNIN-DERIVED COMPOUNDS AND USES THEREOF
The present invention relates to novel lignin-derived compounds and compositions comprising the same and their use as redox flow battery electrolytes. The invention further provides a method for preparing said compounds and compositions as well as a redox flow battery comprising said compounds and compositions. Additionally, an assembly for carrying out the inventive method is provided.